Skip to main content
Erschienen in: Current Osteoporosis Reports 4/2014

01.12.2014 | Therapeutics and Medical Management (E Shane and RA Adler, Section Editors)

Calcium Use in the Management of Osteoporosis: Continuing Questions and Controversies

verfasst von: Cory Wilczynski, Pauline Camacho

Erschienen in: Current Osteoporosis Reports | Ausgabe 4/2014

Einloggen, um Zugang zu erhalten

Abstract

Calcium is a vital element in the health and maintenance of growing and mature bone. The amount of calcium recommended for ingestion varies by age, and these requirements can be met by dietary sources or calcium supplementation. This article reviews the role of calcium in the body and the benefits and risks to calcium supplementation. The effects of calcium on fracture risk reduction, bone density, and bone turnover markers as well as the conflicting data on cardiovascular events and increased risk of nephrolithiasis associated with supplementation are discussed.
Literatur
1.
Zurück zum Zitat Asomaning K, Bertone-Johnson ER, Nasca PC, Hooven F, Pekow PS. The association between body mass index and osteoporosis in patients referred for a bone mineral density examination. J Womens Health. 2006;15(9):1028–34.CrossRef Asomaning K, Bertone-Johnson ER, Nasca PC, Hooven F, Pekow PS. The association between body mass index and osteoporosis in patients referred for a bone mineral density examination. J Womens Health. 2006;15(9):1028–34.CrossRef
2.•
Zurück zum Zitat Moyer VA, Lefevre ML, Siu AL. Vitamin D and calcium supplementation to prevent fractures in adults. Ann Int Med. 2013;159(12):856–7. Available at: http://www.uspreventiveservicestaskforce.org/uspstf12/vitamind/finalrecvitd.htm. This is the USPTF recommendations for calcium and vitamin D use in osteoporosis treatment. Previous recommendations had no question of calcium use in the management of osteoporosis but the new guidelines, given recent articles coming out about cardiovascular event association with supplementation use, have brought use of calcium supplementation into question. Accessed 14 Apr 2014. Moyer VA, Lefevre ML, Siu AL. Vitamin D and calcium supplementation to prevent fractures in adults. Ann Int Med. 2013;159(12):856–7. Available at: http://​www.​uspreventiveserv​icestaskforce.​org/​uspstf12/​vitamind/​finalrecvitd.​htm. This is the USPTF recommendations for calcium and vitamin D use in osteoporosis treatment. Previous recommendations had no question of calcium use in the management of osteoporosis but the new guidelines, given recent articles coming out about cardiovascular event association with supplementation use, have brought use of calcium supplementation into question. Accessed 14 Apr 2014.
6.•
Zurück zum Zitat Booth A, Camacho P. A closer look at calcium absorption and the benefits and risks of dietary vs supplemental calcium. Postgrad Med J. 2013;125(6):73–81. Booth and Camacho’s article directly reviews the difference between calcium supplementation and dietary calcium intake. The benefits of dietary supplementation are evident as well as a review of where calcium is absorbed in the gastrointestinal tract. This was a good source for comparing dietary vs supplement intake.CrossRef Booth A, Camacho P. A closer look at calcium absorption and the benefits and risks of dietary vs supplemental calcium. Postgrad Med J. 2013;125(6):73–81. Booth and Camacho’s article directly reviews the difference between calcium supplementation and dietary calcium intake. The benefits of dietary supplementation are evident as well as a review of where calcium is absorbed in the gastrointestinal tract. This was a good source for comparing dietary vs supplement intake.CrossRef
7.
Zurück zum Zitat Rafferty K, Walters G, Heaney RP. Calcium fortifications: overview and strategies for improving calcium nutrients of the U.S. population. J Food Sci. 2007;72(9):R152–8.PubMedCrossRef Rafferty K, Walters G, Heaney RP. Calcium fortifications: overview and strategies for improving calcium nutrients of the U.S. population. J Food Sci. 2007;72(9):R152–8.PubMedCrossRef
8.
Zurück zum Zitat Christodoulu C, Cooper C. What is osteoporosis? Postgrad Med J. 2003;79:133–8.CrossRef Christodoulu C, Cooper C. What is osteoporosis? Postgrad Med J. 2003;79:133–8.CrossRef
9.
10.
Zurück zum Zitat Cummings RJ, Nevitt MC. Calcium for prevention of osteoporotic fractures in postmenopausal women. J Bone Miner Res. 1997;12(9):1321–9.CrossRef Cummings RJ, Nevitt MC. Calcium for prevention of osteoporotic fractures in postmenopausal women. J Bone Miner Res. 1997;12(9):1321–9.CrossRef
11.
Zurück zum Zitat Chevalley T, Rizzoli R, Nydegger V, et al. Effects of calcium supplements on femoral bone mineral density and vertebral fracture rate in vitamin-D-replete elderly patients. Osteoporosis Int. 1994;4(5):245–52.CrossRef Chevalley T, Rizzoli R, Nydegger V, et al. Effects of calcium supplements on femoral bone mineral density and vertebral fracture rate in vitamin-D-replete elderly patients. Osteoporosis Int. 1994;4(5):245–52.CrossRef
12.
Zurück zum Zitat Cumming RG. Calcium intake and bone mass: a quantitative review of the evidence. Calcif Tissue Int. 1990;47(4):194–201.PubMedCrossRef Cumming RG. Calcium intake and bone mass: a quantitative review of the evidence. Calcif Tissue Int. 1990;47(4):194–201.PubMedCrossRef
13.
Zurück zum Zitat Shea B, Wells G, Cranney A, et al. Meta-analyses of therapies for postmenopausal osteoporosis. VII. Meta-analysis of calcium supplementation for the prevention of postmenopausal osteoporosis. Endocr Rev. 2002;23(4):552–9.PubMedCrossRef Shea B, Wells G, Cranney A, et al. Meta-analyses of therapies for postmenopausal osteoporosis. VII. Meta-analysis of calcium supplementation for the prevention of postmenopausal osteoporosis. Endocr Rev. 2002;23(4):552–9.PubMedCrossRef
16.
Zurück zum Zitat Dawson-Hughes B, Harris S, Krall E, et al. Effects of calcium and vitamin d supplementation on bone density in men and women 65 years of age or older. N Engl J Med. 1997;337(10):670–6.PubMedCrossRef Dawson-Hughes B, Harris S, Krall E, et al. Effects of calcium and vitamin d supplementation on bone density in men and women 65 years of age or older. N Engl J Med. 1997;337(10):670–6.PubMedCrossRef
17.
Zurück zum Zitat Chung M, Balk EM, Brendel M, Ip S, Lau J, Lee J. Vitamin D and calcium: a systemic review of Health Outcomes. Evidence report/technology assessment no. 183. Rockville, MD: Agency for Healthcare Research and Quality; 2009. Available at: www.ncbi.nlm.nih.gov/books/NBK32603/. Accessed 12 Jun 2014. Chung M, Balk EM, Brendel M, Ip S, Lau J, Lee J. Vitamin D and calcium: a systemic review of Health Outcomes. Evidence report/technology assessment no. 183. Rockville, MD: Agency for Healthcare Research and Quality; 2009. Available at: www.​ncbi.​nlm.​nih.​gov/​books/​NBK32603/​. Accessed 12 Jun 2014.
18.
Zurück zum Zitat Chung M, Lee J, Terasawa T, Lau J, Trikalinos TA. Vitamin D with or without calcium supplementation for prevention of cancer fractures: an updated meta-analysis for the US Preventative Services Task Force. Ann Intern Med. 2011;155:827–38.PubMedCrossRef Chung M, Lee J, Terasawa T, Lau J, Trikalinos TA. Vitamin D with or without calcium supplementation for prevention of cancer fractures: an updated meta-analysis for the US Preventative Services Task Force. Ann Intern Med. 2011;155:827–38.PubMedCrossRef
20.
Zurück zum Zitat Prince RL, Devine A, Dhaliwal SS, Dick IM. Effects of calcium supplementation on clinical fracture and bone structure: results of a 5-year, double-blind, placebo-controlled trial in elderly women. Arch Intern Med. 2006;166:869–75.PubMedCrossRef Prince RL, Devine A, Dhaliwal SS, Dick IM. Effects of calcium supplementation on clinical fracture and bone structure: results of a 5-year, double-blind, placebo-controlled trial in elderly women. Arch Intern Med. 2006;166:869–75.PubMedCrossRef
21.
Zurück zum Zitat Peacock M, Liu G, Carey M, et al. Effect of calcium or 25OH vitamin D3 dietary supplementation on bone loss at the hip in men and women over the age of 60. J Clin Endocrinol Metab. 2000;85:3011–9.PubMed Peacock M, Liu G, Carey M, et al. Effect of calcium or 25OH vitamin D3 dietary supplementation on bone loss at the hip in men and women over the age of 60. J Clin Endocrinol Metab. 2000;85:3011–9.PubMed
22.
Zurück zum Zitat Harwood R, Sahota O, Gaynor K, Masud T, Hosking D. A randomised, controlled comparison of different calcium and vitamin D supplementation regimens in elderly women after hip fracture: the Nottingham Neck of Femur (NoNOF) Study. Age Ageing. 2004;33:45–51.PubMedCrossRef Harwood R, Sahota O, Gaynor K, Masud T, Hosking D. A randomised, controlled comparison of different calcium and vitamin D supplementation regimens in elderly women after hip fracture: the Nottingham Neck of Femur (NoNOF) Study. Age Ageing. 2004;33:45–51.PubMedCrossRef
23.
Zurück zum Zitat Larsen ER, Mosekilde L, Foldsprang A. Vitamin D and calcium supplementation prevents osteoporotic fractures in elderly community dwelling residents: a pragmatic population-based 3-year intervention study. J Bone Miner Res. 2004;19:370–8.PubMedCrossRef Larsen ER, Mosekilde L, Foldsprang A. Vitamin D and calcium supplementation prevents osteoporotic fractures in elderly community dwelling residents: a pragmatic population-based 3-year intervention study. J Bone Miner Res. 2004;19:370–8.PubMedCrossRef
24.
Zurück zum Zitat Reid I, Mason B, Horne A, et al. Randomized controlled trial of calcium in healthy older women. Am J Med. 2006;119:777–85.PubMedCrossRef Reid I, Mason B, Horne A, et al. Randomized controlled trial of calcium in healthy older women. Am J Med. 2006;119:777–85.PubMedCrossRef
25.
Zurück zum Zitat Riggs BL, O’Fallon WM, Muhs J, et al. Long-term effects of calcium supplementation on serum parathyroid hormone level, bone turnover, and bone loss in elderly women. J Bone Miner Res. 1998;13(2):168–74.PubMedCrossRef Riggs BL, O’Fallon WM, Muhs J, et al. Long-term effects of calcium supplementation on serum parathyroid hormone level, bone turnover, and bone loss in elderly women. J Bone Miner Res. 1998;13(2):168–74.PubMedCrossRef
27.
Zurück zum Zitat Sambrook P, Birmingham R, Kelly P, et al. Prevention of corticosteroid osteoporosis: a comparison of calcium, calcitriol, and calcitonin. N Engl J Med. 1993;328(24):1747–52.PubMedCrossRef Sambrook P, Birmingham R, Kelly P, et al. Prevention of corticosteroid osteoporosis: a comparison of calcium, calcitriol, and calcitonin. N Engl J Med. 1993;328(24):1747–52.PubMedCrossRef
28.
Zurück zum Zitat Maalouf N, Heller H, Odvina C, Kim P, Sakhaee K. Bisphosphonate-induced hypocalcemia: report of 3 cases and review of the literature. Endocr Prac. 2006;12(1):48–53.CrossRef Maalouf N, Heller H, Odvina C, Kim P, Sakhaee K. Bisphosphonate-induced hypocalcemia: report of 3 cases and review of the literature. Endocr Prac. 2006;12(1):48–53.CrossRef
29.
Zurück zum Zitat Rosen CJ. Letter-Severe hypocalcemia after intravenous bisphosphonate therapy in occult vitamin D deficiency. N Engl J Med. 2003;348(15):1503–4.PubMedCrossRef Rosen CJ. Letter-Severe hypocalcemia after intravenous bisphosphonate therapy in occult vitamin D deficiency. N Engl J Med. 2003;348(15):1503–4.PubMedCrossRef
30.
Zurück zum Zitat Talreja DB. Severe hypocalcemia following a single injection of denosumab in a patient with renal impairment. J Drug Assess. 2012;1:30–3.CrossRef Talreja DB. Severe hypocalcemia following a single injection of denosumab in a patient with renal impairment. J Drug Assess. 2012;1:30–3.CrossRef
31.
Zurück zum Zitat Chennuru S, Koduri J, Baumann MA. Risk factors for hypocalcemia complicating treatment with zoledronic acid. Intern Med J. 2008;38:635–7.PubMedCrossRef Chennuru S, Koduri J, Baumann MA. Risk factors for hypocalcemia complicating treatment with zoledronic acid. Intern Med J. 2008;38:635–7.PubMedCrossRef
32.
Zurück zum Zitat Lips P, Bouillon R, van Schoor NM, et al. Reducing fracture risk with calcium and vitamin D. Clin Endocrinol. 2010;73:277–85.CrossRef Lips P, Bouillon R, van Schoor NM, et al. Reducing fracture risk with calcium and vitamin D. Clin Endocrinol. 2010;73:277–85.CrossRef
33.•
Zurück zum Zitat Aloia JF, Dhaliwal R, Shieh A, et al. Calcium and vitamin d supplementation in postmenopausal women. J Clin Endocrinol Metab. 2013;98(11):E1702–9. Calcium supplementation is highlighted as vital in decreasing bone turnover markers. The decreases in bone alkaline phosphatase and c-telopeptide were seen in those using calcium alone as well as those with calcium combined with vitamin D. This shows the importance of adequate calcium levels regardless of vitamin D status in decreasing bone turnover markers.PubMedCrossRef Aloia JF, Dhaliwal R, Shieh A, et al. Calcium and vitamin d supplementation in postmenopausal women. J Clin Endocrinol Metab. 2013;98(11):E1702–9. Calcium supplementation is highlighted as vital in decreasing bone turnover markers. The decreases in bone alkaline phosphatase and c-telopeptide were seen in those using calcium alone as well as those with calcium combined with vitamin D. This shows the importance of adequate calcium levels regardless of vitamin D status in decreasing bone turnover markers.PubMedCrossRef
34.••
Zurück zum Zitat Cauley JA, Chlebowshki RT, Wactawski-Wende J, et al. Calcium plus vitamin D supplementation and health outcomes five years after active intervention ended: the Women’s Health Initiative. J Womens Health. 2013;22(11):915–29. The results of Cauley et al study is 11 years out, the longest follow-up analysis thus far reported, which showed that there was no significant risk associated with calcium use and CVD. This is a major study that discounts theories that increase plaque deposition is the mechanism of action for increased CVD in supplement users, which has been the proposed mechanism of action of for the link between CVD and calcium supplementation.CrossRef Cauley JA, Chlebowshki RT, Wactawski-Wende J, et al. Calcium plus vitamin D supplementation and health outcomes five years after active intervention ended: the Women’s Health Initiative. J Womens Health. 2013;22(11):915–29. The results of Cauley et al study is 11 years out, the longest follow-up analysis thus far reported, which showed that there was no significant risk associated with calcium use and CVD. This is a major study that discounts theories that increase plaque deposition is the mechanism of action for increased CVD in supplement users, which has been the proposed mechanism of action of for the link between CVD and calcium supplementation.CrossRef
35.
Zurück zum Zitat Jensen C, Holloway L, Block G, et al. Long term effects of nutrient intervention on markers of bone remodeling and calciotropic hormones in late-postmenopausal women. Am J Clin Nutr. 2002;75:1114–20.PubMed Jensen C, Holloway L, Block G, et al. Long term effects of nutrient intervention on markers of bone remodeling and calciotropic hormones in late-postmenopausal women. Am J Clin Nutr. 2002;75:1114–20.PubMed
36.
Zurück zum Zitat Cummings RG, Cummings SR, Nevitt MC, et al. Calcium intake and fracture risk: results from the study of osteoporotic fractures. Am J Epidemiol. 1997;145(10):926–34.PubMedCrossRef Cummings RG, Cummings SR, Nevitt MC, et al. Calcium intake and fracture risk: results from the study of osteoporotic fractures. Am J Epidemiol. 1997;145(10):926–34.PubMedCrossRef
37.
Zurück zum Zitat Borghi L, Meschi T, Amato F, et al. Urinary volume, water and recurrences of idiopathic calcium nephrolithiasis: a 5-year randomized prospective study. J Urol. 1996;155:839–43.PubMedCrossRef Borghi L, Meschi T, Amato F, et al. Urinary volume, water and recurrences of idiopathic calcium nephrolithiasis: a 5-year randomized prospective study. J Urol. 1996;155:839–43.PubMedCrossRef
38.
Zurück zum Zitat Diaz-Lopez B, Cannata-Andia JB. Supplementation of vitamin D and calcium: advantages and risks. Nephrol Dial Transplant. 2006;21:2375–7.PubMedCrossRef Diaz-Lopez B, Cannata-Andia JB. Supplementation of vitamin D and calcium: advantages and risks. Nephrol Dial Transplant. 2006;21:2375–7.PubMedCrossRef
39.
Zurück zum Zitat Haghighi A, Samimagham H, Gahardehi G. Calcium and vitamin d supplementation and risk of kidney stone formation in postmenopausal women. Iran J Kidney Dis. 2013;7(3):210–3.PubMed Haghighi A, Samimagham H, Gahardehi G. Calcium and vitamin d supplementation and risk of kidney stone formation in postmenopausal women. Iran J Kidney Dis. 2013;7(3):210–3.PubMed
40.
Zurück zum Zitat Curhan GC, Willett WC, Rimm EB, Stampfer MJ. A prospective study of dietary calcium and other nutrients and the risk of symptomatic kidney stones. N Engl J Med. 1993;328:833.PubMedCrossRef Curhan GC, Willett WC, Rimm EB, Stampfer MJ. A prospective study of dietary calcium and other nutrients and the risk of symptomatic kidney stones. N Engl J Med. 1993;328:833.PubMedCrossRef
41.
Zurück zum Zitat Curhan GC, Willett WC, Speizer FE, Spiegelman D, Stampfer MJ. Comparison of dietary calcium with supplemental calcium and other nutrients as factors affecting the risk of kidney stones in women. Ann Intern Med. 1997;126:497.PubMedCrossRef Curhan GC, Willett WC, Speizer FE, Spiegelman D, Stampfer MJ. Comparison of dietary calcium with supplemental calcium and other nutrients as factors affecting the risk of kidney stones in women. Ann Intern Med. 1997;126:497.PubMedCrossRef
42.
Zurück zum Zitat Sakhaee K, Poindexter JR, Griffith CS, Pak CYC. Stone forming risk of calcium citrate supplementation in healthy postmenopausal women. J Urol. 2004;172:958–61.PubMedCrossRef Sakhaee K, Poindexter JR, Griffith CS, Pak CYC. Stone forming risk of calcium citrate supplementation in healthy postmenopausal women. J Urol. 2004;172:958–61.PubMedCrossRef
43.
Zurück zum Zitat Bolland MJ, Avenell A, Baron JA, et al. Effect of calcium supplements on risk of myocardial infarction and cardiovascular events: meta-analysis. BMJ. 2010;341:c3691. Accessed 30 Apr 2014: BMJ.com. Bolland MJ, Avenell A, Baron JA, et al. Effect of calcium supplements on risk of myocardial infarction and cardiovascular events: meta-analysis. BMJ. 2010;341:c3691. Accessed 30 Apr 2014: BMJ.com.
44.
Zurück zum Zitat Rautiainen S, Wang L, Manson JE, Sesso HD. The role of calcium in the prevention of cardiovascular disease: a review of observational studies and randomized clinical trials. Curr Atherolscler Rep. 2013;15:362.CrossRef Rautiainen S, Wang L, Manson JE, Sesso HD. The role of calcium in the prevention of cardiovascular disease: a review of observational studies and randomized clinical trials. Curr Atherolscler Rep. 2013;15:362.CrossRef
45.
Zurück zum Zitat Paik JM, Curhan GC, Sun Q, et al. Calcium supplement intake and risk of cardiovascular disease in women. Osteoporos Int. 2014;25:2047–56.PubMedCrossRef Paik JM, Curhan GC, Sun Q, et al. Calcium supplement intake and risk of cardiovascular disease in women. Osteoporos Int. 2014;25:2047–56.PubMedCrossRef
46.
Zurück zum Zitat Bolland MJ, Barber PA, Doughty RN, Mason B, Horne A, Ames R, et al. Vascular events in healthy older women receiving calcium supplementation: randomized controlled trial. BMJ. 2008;336:262–6.PubMedCrossRefPubMedCentral Bolland MJ, Barber PA, Doughty RN, Mason B, Horne A, Ames R, et al. Vascular events in healthy older women receiving calcium supplementation: randomized controlled trial. BMJ. 2008;336:262–6.PubMedCrossRefPubMedCentral
47.
Zurück zum Zitat Xiao Q, Murphy RA, Houston DK, Harris TB, Chow WH, Park Y. Dietary and supplemental calcium intake and cardiovascular disease mortality: the National Institutes of Health-AARP diet and health study. JAMA Intern Med. 2013;173:639–46.PubMedCrossRefPubMedCentral Xiao Q, Murphy RA, Houston DK, Harris TB, Chow WH, Park Y. Dietary and supplemental calcium intake and cardiovascular disease mortality: the National Institutes of Health-AARP diet and health study. JAMA Intern Med. 2013;173:639–46.PubMedCrossRefPubMedCentral
48.
Zurück zum Zitat Van Hemelrijck M, Michaelsson K, Linseisen J, Rohrmann S. Calcium intake and serum concentration in relation to risk of cardiovascular death in NHANES III. PLoS One. 2013;8(4):e61037.PubMedCrossRefPubMedCentral Van Hemelrijck M, Michaelsson K, Linseisen J, Rohrmann S. Calcium intake and serum concentration in relation to risk of cardiovascular death in NHANES III. PLoS One. 2013;8(4):e61037.PubMedCrossRefPubMedCentral
49.
Zurück zum Zitat Baron JA, Beach M, Mandel JS, van Stolk RU, Haile RW, Sandler RS, et al. Calcium supplements for the prevention of colorectal adenomas. Calcium Polyp Prevention Study Group. N Engl J Med. 1999;340:101–7.PubMedCrossRef Baron JA, Beach M, Mandel JS, van Stolk RU, Haile RW, Sandler RS, et al. Calcium supplements for the prevention of colorectal adenomas. Calcium Polyp Prevention Study Group. N Engl J Med. 1999;340:101–7.PubMedCrossRef
50.
Zurück zum Zitat Downing L, Islam MA. Influence of calcium supplements on the occurrence of cardiovascular events. Am J Health Syst Pharm. 2013;70(13):1132–9.PubMedCrossRef Downing L, Islam MA. Influence of calcium supplements on the occurrence of cardiovascular events. Am J Health Syst Pharm. 2013;70(13):1132–9.PubMedCrossRef
51.
Zurück zum Zitat Lewis J, Rejnmark L, Ivey K, Prentice R, Prince R. The cardiovascular safety of calcium supplementation with or without vitamin D in elderly women: a collaborative meta-analysis of published and unpublished trial level evidence from randomized controlled trials. J Bone Miner Res. 2013;28:1002. Lewis J, Rejnmark L, Ivey K, Prentice R, Prince R. The cardiovascular safety of calcium supplementation with or without vitamin D in elderly women: a collaborative meta-analysis of published and unpublished trial level evidence from randomized controlled trials. J Bone Miner Res. 2013;28:1002.
52.
Zurück zum Zitat Ebeling P, English D, Nowson C, Daly R, Khan B. Long term effects of higher dietary calcium intake on vertebral fractures and severe abdominal aortic calcification in older Australians. J Bone Miner Res. 2013;28:S492. Ebeling P, English D, Nowson C, Daly R, Khan B. Long term effects of higher dietary calcium intake on vertebral fractures and severe abdominal aortic calcification in older Australians. J Bone Miner Res. 2013;28:S492.
53.
Zurück zum Zitat Bauer D, Harrison S, Cawthorn P, Barrett-Connor E, Shikany J, Ensrud K, et al. Dietary and supplemental calcium intake and the risk of mortality in older men: the MrOS study. J Bone Miner Res. 2013;28:1001. Bauer D, Harrison S, Cawthorn P, Barrett-Connor E, Shikany J, Ensrud K, et al. Dietary and supplemental calcium intake and the risk of mortality in older men: the MrOS study. J Bone Miner Res. 2013;28:1001.
54.
Zurück zum Zitat Bostick RM, Kushi LH, Wu Y, Meyer KA, Sellers TA, Folsom AR. Relation of calcium, vitamin D, and diary food intake to ischemic heart disease mortality among postmenopausal women. Am J Epidemiol. 1999;149:151–61.PubMedCrossRef Bostick RM, Kushi LH, Wu Y, Meyer KA, Sellers TA, Folsom AR. Relation of calcium, vitamin D, and diary food intake to ischemic heart disease mortality among postmenopausal women. Am J Epidemiol. 1999;149:151–61.PubMedCrossRef
55.
Zurück zum Zitat Iso H, Stampfer MJ, Manson JE, et al. Prospective study of calcium, potassium, and magnesium intake and risk of stroke in women. Stroke. 1999;30:1772–9.PubMedCrossRef Iso H, Stampfer MJ, Manson JE, et al. Prospective study of calcium, potassium, and magnesium intake and risk of stroke in women. Stroke. 1999;30:1772–9.PubMedCrossRef
56.
Zurück zum Zitat Al-Delaimy WK, Rimm E, Willett WC, et al. A prospective study of calcium intake from diet and supplements and risk of ischemic heart disease among men. Am J Clin Nutr. 2003;77:814–8.PubMed Al-Delaimy WK, Rimm E, Willett WC, et al. A prospective study of calcium intake from diet and supplements and risk of ischemic heart disease among men. Am J Clin Nutr. 2003;77:814–8.PubMed
57.
Zurück zum Zitat National Osteoporosis Foundation responds to the U.S. Preventive Services Task Force recommendations on Calcium and Vitamin D. National Osteoporosis Foundation. 2013 Feb. http://nof.org/news/903. Accessed 16 Apr 2014. National Osteoporosis Foundation responds to the U.S. Preventive Services Task Force recommendations on Calcium and Vitamin D. National Osteoporosis Foundation. 2013 Feb. http://​nof.​org/​news/​903. Accessed 16 Apr 2014.
Metadaten
Titel
Calcium Use in the Management of Osteoporosis: Continuing Questions and Controversies
verfasst von
Cory Wilczynski
Pauline Camacho
Publikationsdatum
01.12.2014
Verlag
Springer US
Erschienen in
Current Osteoporosis Reports / Ausgabe 4/2014
Print ISSN: 1544-1873
Elektronische ISSN: 1544-2241
DOI
https://doi.org/10.1007/s11914-014-0234-z

Weitere Artikel der Ausgabe 4/2014

Current Osteoporosis Reports 4/2014 Zur Ausgabe

Therapeutics and Medical Management (E Shane and RA Adler, Section Editors)

Anabolic and Antiresorptive Therapy for Osteoporosis: Combination and Sequential Approaches

Skeletal Development (E Schipani and E Zelzer, Section Editors)

Aerobic Glycolysis in Osteoblasts

Skeletal Development (E Schipani and E Zelzer, Section Editors)

Extracellular Matrix and Developing Growth Plate

Imaging (T Lang and F Wehrli, Section Editors)

Micro- and Nano-CT for the Study of Bone Ultrastructure

Therapeutics and Medical Management (E Shane and RA Adler, Section Editors)

Osteoporosis Diagnosis in Men: The T-Score Controversy Revisited

Arthropedia

Grundlagenwissen der Arthroskopie und Gelenkchirurgie. Erweitert durch Fallbeispiele, Videos und Abbildungen. 
» Jetzt entdecken

Update Orthopädie und Unfallchirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.